Cargando…

Online calculator to predict early mortality in patient with surgically treated recurrent lower-grade glioma

PURPOSE: The aim of this study was to investigate the epidemiological characteristics and associated risk factors of recurrent lower-grade glioma [LGG] (WHO grades II and III) according to the 2016 updated WHO classification paradigm and finally develop a model for predicting early mortality (succum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Ruolun, Zhao, Chao, Li, Jianguo, Yang, Fengdong, Xue, Yake, Wei, Xinting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796632/ https://www.ncbi.nlm.nih.gov/pubmed/35086512 http://dx.doi.org/10.1186/s12885-022-09225-9

Ejemplares similares

Preoperative Predictors of Early Mortality Risk in Isocitrate Dehydrogenase-Wild-Type Glioblastoma Patients Treated with Standard Therapy
por: Zhao, Chao, et al.
Publicado: (2021)

Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas
por: Du, Wei, et al.
Publicado: (2015)

The new oncogene transmembrane protein 60 is a potential therapeutic target in glioma
por: Yang, Fengdong, et al.
Publicado: (2023)

Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
por: Du, Wei, et al.
Publicado: (2021)

Preoperative Prediction of Meningioma Consistency via Machine Learning-Based Radiomics
por: Zhai, Yixuan, et al.
Publicado: (2021)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
por: Wei, Ruo-Lun, et al.
Publicado: (2020)

Resilience in Lower Grade Glioma Patients
por: Fröhlich, Ellen, et al.
Publicado: (2022)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas
por: Duan, Wen-chao, et al.
Publicado: (2018)

Multicellular “hotspots” harbor high-grade potential in lower-grade gliomas
por: Kirby, Alastair J, et al.
Publicado: (2021)

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
por: Guan, Xiaowei, et al.
Publicado: (2014)

Integrated Multi-Omics Maps of Lower-Grade Gliomas
por: Binder, Hans, et al.
Publicado: (2022)

Seizures in patients with IDH-mutated lower grade gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas
por: Gregucci, Fabiana, et al.
Publicado: (2022)

PANX2 and brain lower grade glioma genesis: A bioinformatic analysis
por: Xu, XiaoXue, et al.
Publicado: (2021)

Re-irradiation alternatives for recurrent high-grade glioma
por: Dong, Yuanli, et al.
Publicado: (2016)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Repeated Awake Surgical Resection(s) for Recurrent Diffuse Low-Grade Gliomas: Why, When, and How to Reoperate?
por: Duffau, Hugues
Publicado: (2022)

Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas
por: Wang, Lei-Ming, et al.
Publicado: (2019)

Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas
por: Fan, Kun, et al.
Publicado: (2017)

Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)

DNA demethylation is associated with malignant progression of lower-grade gliomas
por: Nomura, Masashi, et al.
Publicado: (2019)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

MPC-18 CATEGORIZATION OF LOWER GRADE GLIOMA USING ONCOPANEL
por: Uchida, Hiroyuki, et al.
Publicado: (2019)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomas
por: Yu, Hai, et al.
Publicado: (2021)

Establishment of patient-derived organoid models of lower-grade glioma
por: Abdullah, Kalil G, et al.
Publicado: (2021)

A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
por: Qian, Xi-Feng, et al.
Publicado: (2022)

Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis
por: Liang, Ruofei, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio and Its Changes are Related to Grade II–IV Glioma Recurrence
por: Ma, Lianghua, et al.
Publicado: (2020)

A survival analysis of surgically treated incidental low-grade glioma patients
por: Zeng, Lingcheng, et al.
Publicado: (2021)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
por: Guo, Jin-Cheng, et al.
Publicado: (2021)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

Surgical Outcomes of High-Grade Spinal Cord Gliomas
por: Seki, Toshitaka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3dc2tdoc4sb6h7cvcmb7fhl1rm